Healthequity (NASDAQ:HQY) Rating Lowered to Hold at BidaskClub
A number of other research analysts also recently issued reports on HQY. Bank of America upgraded shares of Healthequity from a neutral rating to a buy rating and boosted their target price for the company from $75.00 to $90.00 in a research report on Friday, July 19th. Raymond James boosted their target price on shares of Healthequity from $85.00 to $90.00 and gave the company an outperform rating in a research report on Friday, July 19th. JPMorgan Chase & Co. set a $80.00 target price on shares of Healthequity and gave the company an overweight rating in a research report on Wednesday, June 5th. Zacks Investment Research upgraded shares of Healthequity from a strong sell rating to a hold rating in a research report on Tuesday, May 21st. Finally, Citigroup reiterated a buy rating on shares of Healthequity in a research report on Friday, June 28th. Three analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Healthequity currently has a consensus rating of Buy and a consensus target price of $87.92.
Shares of NASDAQ:HQY traded down $0.94 during trading on Wednesday, reaching $62.25. The stock had a trading volume of 14,845 shares, compared to its average volume of 874,132. The business’s fifty day moving average is $72.73. The company has a current ratio of 15.60, a quick ratio of 15.59 and a debt-to-equity ratio of 0.07. Healthequity has a 52 week low of $50.29 and a 52 week high of $101.58. The stock has a market capitalization of $4.24 billion, a PE ratio of 65.75, a price-to-earnings-growth ratio of 3.32 and a beta of 1.47.
In other news, VP Darcy G. Mott sold 4,000 shares of the company’s stock in a transaction on Monday, July 22nd. The shares were sold at an average price of $79.56, for a total value of $318,240.00. Following the completion of the sale, the vice president now owns 54,000 shares in the company, valued at approximately $4,296,240. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Angelique Christine Hill sold 9,500 shares of the company’s stock in a transaction on Friday, July 12th. The stock was sold at an average price of $71.40, for a total transaction of $678,300.00. Following the completion of the sale, the vice president now owns 15,887 shares of the company’s stock, valued at approximately $1,134,331.80. The disclosure for this sale can be found here. In the last quarter, insiders sold 37,899 shares of company stock valued at $2,780,851. Company insiders own 3.70% of the company’s stock.
Hedge funds and other institutional investors have recently bought and sold shares of the company. Meeder Asset Management Inc. bought a new stake in shares of Healthequity in the 2nd quarter worth $25,000. BerganKDV Wealth Management LLC bought a new position in Healthequity during the second quarter valued at about $26,000. FTB Advisors Inc. bought a new position in Healthequity during the second quarter valued at about $27,000. Manchester Capital Management LLC bought a new position in Healthequity during the first quarter valued at about $36,000. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. bought a new position in Healthequity during the second quarter valued at about $39,000. Hedge funds and other institutional investors own 97.10% of the company’s stock.
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Recommended Story: Percentage Gainers
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.